Gene That Mediates Cisplatin Resistance in Ovarian Cancer Identified

by Sheela Philomena on  April 17, 2013 at 1:17 PM Genetics & Stem Cells News
RSS Email Print This Page Comment
Font : A-A+

In ovarian cancer, the gene that mediates cisplatin resistance has been discovered by scientists. Mechanisms of resistance typically include reduced platinum uptake and increased platinum export.
 Gene That Mediates Cisplatin Resistance in Ovarian Cancer Identified
Gene That Mediates Cisplatin Resistance in Ovarian Cancer Identified

In this issue of the Journal of Clinical Investigation, Anil Sood and colleagues at M.D. Anderson Cancer Center identified a cellular membrane protein, ATP11B, that mediates cisplatin resistance in ovarian cancer cells. They found that ATP11B expression was correlated with higher tumor grade in human ovarian cancer samples and with cisplatin-resistance in human ovarian cancer cell lines. Further, loss of ATP11B restored the sensitivity of ovarian cancer cell lines to cisplatin and reduced ovarian tumor growth in mice. These findings suggest that ATP11B could serve as a therapeutic target to overcome cisplatin resistance.

Source: Eurekalert

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
Notify me when reply is posted
I agree to the terms and conditions

Related Links

More News on:

DNA Finger Printing Ovarian Cancer Cancer and Homeopathy Cancer Facts Cancer Tattoos A Body Art Testicular Cancer Weaver Syndrome Meigs Syndrome Ovarian Pain 

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook

News Category

News Archive